Stay updated with breaking news from Accoya. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Coya Therapeutics’ (NASDAQ:COYA – Get Rating) lock-up period will end on Tuesday, June 27th. Coya Therapeutics had issued 3,050,000 shares in its IPO on December 29th. The total size of the offering was $15,250,000 based on an initial share price of $5.00. Shares of the company owned by major shareholders and company insiders will be […]
Coya Therapeutics, Inc. (NASDAQ:COYA – Get Rating) was the recipient of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 44,200 shares, an increase of 65.5% from the May 15th total of 26,700 shares. Currently, 0.6% of the company’s shares are short sold. Based […]
Coya Therapeutics, Inc. (NASDAQ:COYA – Get Rating) was the target of a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 44,200 shares, a growth of 65.5% from the May 15th total of 26,700 shares. Currently, 0.6% of the company’s shares are sold short. Based […]
Coya Therapeutics (NASDAQ:COYA – Get Rating) had its target price raised by Chardan Capital from $9.00 to $11.00 in a research report released on Wednesday morning, The Fly reports. Separately, BTIG Research began coverage on Coya Therapeutics in a research note on Thursday, May 18th. They set a buy rating on the stock. Coya Therapeutics […]
Houston, TX, June 8, 2023 - (ACN Newswire) - Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing multiple therapeutic programs intended to